[ad_1] Akebia to host conference call at 8:00 a.m. ET Vadadustat NDA assigned a PDUFA date of March 27, 2024 Vadadustat approved in 36 countries, including Australia and Taiwan Akebia…
Tag: Akebia Therapeutics
Akebia Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
[ad_1] Akebia to host conference call on May 8 at 8:30 a.m. ET Announced vadadustat is now approved in 32 countries following European Commission marketing authorization Expects a response to…